NASDAQ:SANA Sana Biotechnology Q4 2024 Earnings Results & Report $2.36 -0.08 (-3.09%) As of 12:17 PM Eastern This is a fair market value price provided by Massive. Learn more. Sana Biotechnology beat analyst earnings expectations in its Q4 2024 results, released March 17, 2025. The company reported EPS of -$0.23 versus the -$0.25 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ4 2024Report DateMarch 17, 2025TimeBefore Market OpensConference Call5:00 PM ET Sana Biotechnology EPS ResultsActual EPS-$0.23Consensus EPS -$0.25Beat/MissBeat by +$0.02One Year Ago EPSN/AEPS Beat Rate7 of last 8 quartersSana Biotechnology Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Annual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Annual report(10-K) Sana Biotechnology Q4 2024 Earnings FAQ Did Sana Biotechnology beat earnings estimates for Q4 2024? Sana Biotechnology (NASDAQ:SANA) reported earnings of -$0.23 per share for Q4 2024, beating the consensus estimate of -$0.25. The report was announced on Monday, March 17, 2025. Sana Biotechnology Earnings HeadlinesSana Biotechnology Reports Q3 Profit; Advances Cell Therapy Programs Toward Clinical TrialsNovember 6, 2026 | rttnews.comSana Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 6, 2026 | marketscreener.comMYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.November 11 at 1:00 AM | Paradigm Press (Ad)Sana Biotechnology Reports Third Quarter 2026 Financial Results and Business UpdatesNovember 5, 2026 | markets.businessinsider.comSana Biotechnology, Inc. (SANA) Analyst Insights, Price Targets & Recommendations - Yahoo FinanceNovember 3, 2026 | finance.yahoo.comSana Biotechnology: A Shot At DiabetesOctober 13, 2026 | seekingalpha.comSee More Sana Biotechnology Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sana Biotechnology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sana Biotechnology and other key companies, straight to your email. Email Address About Sana BiotechnologySana Biotechnology (NASDAQ:SANA) is a clinical-stage biotechnology company founded in 2018 and headquartered in Seattle. It develops engineered cells intended to treat a range of diseases, including cancer, autoimmune disorders and conditions that may be addressed through cell replacement. The company’s research focuses on modifying cells to improve their therapeutic properties, including approaches designed to help transplanted cells evade immune rejection. Its programs include engineered immune-cell therapies and cell-replacement treatments, such as work involving insulin-producing cells for type 1 diabetes. These are investigational programs, not approved products. Sana conducts research and development in the United States, with locations including Seattle, South San Francisco and Cambridge. Its chief executive officer is Steve Harr.View Sana Biotechnology ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Amazon's Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI DemandThe Trade Desk Beats on Revenue, But the Fine Print MattersWhy Kinder Morgan's Chairman Just Bought $15 Million in StockA $4 Billion Jolt: NRG Energy Powers Data Center Ambitions3 Stocks Wall Street Likes More Than the Market DoesD-Wave Quantum Has Long-Term Potential, But Is Now the Time to Buy? Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
